Aflac (AFL) to Release Quarterly Earnings on Wednesday

Aflac (NYSE:AFL) is set to post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect Aflac to post earnings of $1.67 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.10 billion. During the same period last year, the business earned $1.58 EPS. The company’s revenue was down .7% compared to the same quarter last year. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Stock Up 0.0 %

NYSE:AFL opened at $109.80 on Tuesday. Aflac has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The stock has a market capitalization of $62.39 billion, a P/E ratio of 12.12, a P/E/G ratio of 2.62 and a beta of 0.95. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The company’s 50-day simple moving average is $110.41 and its 200-day simple moving average is $97.16.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s payout ratio is currently 22.08%.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now owns 18,158 shares of the company’s stock, valued at $1,796,552.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on AFL. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Citigroup raised their price target on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Piper Sandler raised their price target on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Truist Financial raised their price target on shares of Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, Morgan Stanley raised their price target on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aflac presently has an average rating of “Hold” and an average price target of $97.53.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.